Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 38

1.

Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activation.

Yang HC, Xing S, Shan L, O'Connell K, Dinoso J, Shen A, Zhou Y, Shrum CK, Han Y, Liu JO, Zhang H, Margolick JB, Siliciano RF.

J Clin Invest. 2009 Nov;119(11):3473-86. doi: 10.1172/JCI39199. Epub 2009 Oct 1.

2.

From reactivation of latent HIV-1 to elimination of the latent reservoir: the presence of multiple barriers to viral eradication.

Shan L, Siliciano RF.

Bioessays. 2013 Jun;35(6):544-52. doi: 10.1002/bies.201200170. Epub 2013 Apr 24. Review.

3.

Therapeutics for HIV-1 reactivation from latency.

Sgarbanti M, Battistini A.

Curr Opin Virol. 2013 Aug;3(4):394-401. doi: 10.1016/j.coviro.2013.06.001. Epub 2013 Jun 28. Review.

PMID:
23810462
4.

The development of immune-modulating compounds to disrupt HIV latency.

Remoli AL, Marsili G, Battistini A, Sgarbanti M.

Cytokine Growth Factor Rev. 2012 Aug-Oct;23(4-5):159-72. doi: 10.1016/j.cytogfr.2012.05.003. Epub 2012 Jul 4. Review.

PMID:
22766356
5.

Therapeutic Approaches to Eradicate Latent HIV-1 in Resting CD4+ T Cells.

Sluis-Cremer N.

Curr Top Med Chem. 2016;16(10):1191-7. Review.

PMID:
26324046
6.

HIV-1 regulation of latency in the monocyte-macrophage lineage and in CD4+ T lymphocytes.

Redel L, Le Douce V, Cherrier T, Marban C, Janossy A, Aunis D, Van Lint C, Rohr O, Schwartz C.

J Leukoc Biol. 2010 Apr;87(4):575-88. doi: 10.1189/jlb.0409264. Epub 2009 Oct 2. Review.

7.

Targeting NF-κB signaling with protein kinase C agonists as an emerging strategy for combating HIV latency.

Jiang G, Dandekar S.

AIDS Res Hum Retroviruses. 2015 Jan;31(1):4-12. doi: 10.1089/AID.2014.0199. Review.

8.

Targeting HIV latency: pharmacologic strategies toward eradication.

Xing S, Siliciano RF.

Drug Discov Today. 2013 Jun;18(11-12):541-51. doi: 10.1016/j.drudis.2012.12.008. Epub 2012 Dec 25. Review.

9.

Experimental approaches to the study of HIV-1 latency.

Han Y, Wind-Rotolo M, Yang HC, Siliciano JD, Siliciano RF.

Nat Rev Microbiol. 2007 Feb;5(2):95-106. Review.

PMID:
17224919
10.

Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies.

Colin L, Van Lint C.

Retrovirology. 2009 Dec 4;6:111. doi: 10.1186/1742-4690-6-111. Review.

11.

Regulation of HIV-1 latency by T-cell activation.

Williams SA, Greene WC.

Cytokine. 2007 Jul;39(1):63-74. Epub 2007 Jul 20. Review.

12.
13.

Progress and challenges in the use of latent HIV-1 reactivating agents.

Shang HT, Ding JW, Yu SY, Wu T, Zhang QL, Liang FJ.

Acta Pharmacol Sin. 2015 Aug;36(8):908-16. doi: 10.1038/aps.2015.22. Epub 2015 Jun 1. Review.

14.

Facts and fiction: cellular models for high throughput screening for HIV-1 reactivating drugs.

Planelles V, Wolschendorf F, Kutsch O.

Curr HIV Res. 2011 Dec 1;9(8):568-78. Review.

15.

Recent developments in human immunodeficiency virus-1 latency research.

Chan CN, Dietrich I, Hosie MJ, Willett BJ.

J Gen Virol. 2013 May;94(Pt 5):917-32. doi: 10.1099/vir.0.049296-0. Epub 2013 Jan 30. Review.

16.

Recent developments in the search for a cure for HIV-1 infection: targeting the latent reservoir for HIV-1.

Siliciano JD, Siliciano RF.

J Allergy Clin Immunol. 2014 Jul;134(1):12-9. doi: 10.1016/j.jaci.2014.05.026. Epub 2014 Jun 26. Review.

PMID:
25117799
17.
18.

Reactivation of latent HIV by histone deacetylase inhibitors.

Shirakawa K, Chavez L, Hakre S, Calvanese V, Verdin E.

Trends Microbiol. 2013 Jun;21(6):277-85. doi: 10.1016/j.tim.2013.02.005. Epub 2013 Mar 18. Review.

19.

HIV type-1 latency: targeted induction of proviral reservoirs.

Graci JD, Colacino JM, Peltz SW, Dougherty JP, Gu Z.

Antivir Chem Chemother. 2009;19(5):177-87. Review.

PMID:
19483266
20.

Cellular and molecular mechanisms involved in the establishment of HIV-1 latency.

Donahue DA, Wainberg MA.

Retrovirology. 2013 Feb 1;10:11. doi: 10.1186/1742-4690-10-11. Review.

Supplemental Content

Support Center